Omnicell to acquire PSG’s 340B software-enabled service business
MOUNTAIN VIEW, Calif. — Omnicell announced it has entered into a definitive agreement with Pharmaceutical Strategies Group (PSG) to acquire its 340B Link business for total aggregate cash consideration of $225 million, subject to customary adjustments. The acquisition will add a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals,
